Osmotica Pharmaceuticals (OSMT) Sets New 1-Year Low at $6.11

Shares of Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) hit a new 52-week low on Friday . The stock traded as low as $6.11 and last traded at $6.07, with a volume of 800 shares changing hands. The stock had previously closed at $6.54.

The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.07 and a current ratio of 1.29.

Several hedge funds have recently added to or reduced their stakes in OSMT. American International Group Inc. bought a new stake in shares of Osmotica Pharmaceuticals during the 4th quarter worth about $50,000. Northern Trust Corp bought a new stake in shares of Osmotica Pharmaceuticals during the 4th quarter worth about $615,000. Geode Capital Management LLC bought a new stake in shares of Osmotica Pharmaceuticals during the 4th quarter worth about $668,000. JW Asset Management LLC bought a new stake in shares of Osmotica Pharmaceuticals during the 4th quarter worth about $1,744,000. Finally, Sofinnova Investments Inc. bought a new stake in shares of Osmotica Pharmaceuticals during the 4th quarter worth about $1,961,000. Institutional investors own 12.76% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was published by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.wkrb13.com/2019/03/15/osmotica-pharmaceuticals-osmt-sets-new-1-year-low-at-6-11.html.

About Osmotica Pharmaceuticals (NASDAQ:OSMT)

Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, develops, manufactures, and commercializes specialty products that target markets with underserved patient populations. The company's promoted approved products include specialty neurology products, such as M-72 to treat ADHD; Osmolex ER to treat Parkinson's and drug-induced extrapyramidal reactions in adults; Lorzone to treat muscle spasms; and ConZip for pain, as well as women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods.

Featured Article: What are trading strategies for the 52-week high/low?

Receive News & Ratings for Osmotica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Osmotica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply